45414-311 : Fludarabine Phosphate 10 mg Oral Tablet


NDC45414-311
Labeler: Antisoma Research Limited
Drug Name:  Fludarabine Phosphate
Rev. Date: 


Appearance:


Markings: LN
Shapes:  Oval
Colors:  Pink
Size (mm): 0
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

Active Ingredients:

  • Fludarabine

Inactive Ingredients:

  • Microcrystalline Cellulose
  • Lactose Monohydrate
  • Colloidal Anhydrous Silicon Dioxide
  • Croscarmellose Sodium
  • Magnesium Stearate
  • Hypromellose
  • Talc
  • Titanium Dioxide (E171)
  • Ferric Oxide Pigment (Red/E172, Yellow/E172)

Related Products:

Based on records with the same trade name.
  • 0069-9321 Fludarabine Phosphate 25 mg/ml Intravenous Injection by Pfizer Laboratories Div Pfizer Inc.
  • 0480-9772 Fludarabine Phosphate 25 mg/ml Intravenous Injection, Solution by Teva Pharmaceuticals, Inc.
  • 0527-1242 Fludarabine Phosphate 25 mg/ml Intravenous Injection by Lannett Company, Inc.
  • 0703-4852 Fludarabine Phosphate 25 mg/ml Intravenous Injection by Teva Parenteral Medicines, Inc.
  • 0703-5854 Fludarabine Phosphate 50 mg/2ml Intravenous Injection, Powder, Lyophilized, for Solution by Teva Parenteral Medicines, Inc.
  • 16729-131 Fludarabine Phosphate 25 mg/ml Intravenous Injection by Accord Healthcare, Inc.
  • 24201-237 Fludarabine Phosphate 25 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Leucadia Pharmaceuticals
  • 25021-205 Fludarabine Phosphate 50 mg/2ml Intravenous Injection by Sagent Pharmaceutical, Inc.
  • 25021-237 Fludarabine Phosphate 25 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Sagent Pharmaceuticals
  • 25021-242 Fludarabine Phosphate 25 mg/ml Intravenous Injection, Solution by Sagent Pharmaceuticals
  • 45963-609 Fludarabine Phosphate 50 mg/2ml Intravenous Injection, Powder, Lyophilized, for Solution by Actavis Pharma, Inc.
  • 45963-621 Fludarabine Phosphate 25 mg/ml Intravenous Injection, Solution by Actavis Pharma, Inc.
  • 59923-604 Fludarabine Phosphate 25 mg/ml Intravenous Injection by Areva Pharmaceuticals
  • 61703-344 Fludarabine Phosphate 50 mg/2ml Intravenous Injection, Powder, Lyophilized, for Solution by Hospira Worldwide, Inc.
  • 66758-046 Fludarabine Phosphate 25 mg/ml Intravenous Injection, Solution by Sandoz Inc
  • 67457-238 Fludarabine Phosphate 25 mg/ml Intravenous Injection, Solution by Mylan Institutional LLC
  • 67457-268 Fludarabine Phosphate 25 mg/ml Intravenous Injection, Solution by Mylan Institutional LLC
  • 67457-495 Fludarabine Phosphate 25 mg/ml Intravenous Injection by Mylan Institutional LLC

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 45414-311 QR Code

< Prev: 45405-002Next: 45545-001 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.